Description

5-(5-[1-(3,5-Dimethoxybenzyl)Piperidin-4-Yl]-1,2,4-Oxadiazol-3-Yl)-2-(Trifluoromethyl)Pyridine is a high-purity, advanced pharmaceutical intermediate designed for critical synthesis pathways. This compound matters for its role as a key building block in the development of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system and metabolic disorders. Pharmaceutical R&D teams and fine chemical manufacturers need this material for its precise structural features, which enable the construction of complex molecules with potential therapeutic activity.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, particularly in medicinal chemistry research.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core scaffold for constructing potential APIs targeting specific biological receptors.
• Biochemical Research: Used as a reference standard or probe compound in pharmacological and pharmacokinetic studies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Library Synthesis: Employed in the generation of focused chemical libraries for high-throughput screening in drug discovery programs.

Basic Information

Product Name	5-(5-[1-(3,5-Dimethoxybenzyl)Piperidin-4-Yl]-1,2,4-Oxadiazol-3-Yl)-2-(Trifluoromethyl)Pyridine
CAS No.	909662-35-7
Molecular Formula	C23H25F3N4O3
Molecular Weight	462.47 g/mol
Synonyms	2-(Trifluoromethyl)-5-[5-[1-[(3,5-dimethoxyphenyl)methyl]-4-piperidinyl]-1,2,4-oxadiazol-3-yl]pyridine; 909662-35-7; 5-(5-(1-(3,5-Dimethoxybenzyl)piperidin-4-yl)-1,2,4-oxadiazol-3-yl)-2-(trifluoromethyl)pyridine; 2-(Trifluoromethyl)-5-(5-(1-(3,5-dimethoxybenzyl)piperidin-4-yl)-1,2,4-oxadiazol-3-yl)pyridine; 5-[5-[1-[(3,5-Dimethoxyphenyl)methyl]-4-piperidinyl]-1,2,4-oxadiazol-3-yl]-2-(trifluoromethyl)pyridine
EINECS	Contact for details

Quality Control

Our 5-(5-[1-(3,5-Dimethoxybenzyl)Piperidin-4-Yl]-1,2,4-Oxadiazol-3-Yl)-2-(Trifluoromethyl)Pyridine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing batch-specific results are provided and can be tailored to meet specific client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials such as strong alkalis and fluorides. For long-term storage, consider inert atmosphere conditions to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.